Skip to main content
Top
Published in: Drug Safety 1/2007

01-01-2007 | Original Research Article

Emergency Department Visits Caused by Adverse Drug Events

Results of a French Survey

Authors: Patrice Queneau, Bernard Bannwarth, Françoise Carpentier, Jean-Michel Guliana, Jacques Bouget, Béatrice Trombert, Xavier Leverve, Frédéric Lapostolle, Stephen W Borron, Professor Frédéric Adnet

Published in: Drug Safety | Issue 1/2007

Login to get access

Abstract

Background: Adverse drug events (ADEs) are a substantial cause of hospital admissions. However, little is known about the incidence, preventability and severity of ADEs resulting in emergency department visits. To address this issue, we conducted a prospective survey in emergency departments of French public hospitals.
Methods: This study was performed over two periods of 1 week each, one in June 1999 and one in December 1999, in emergency departments of five university hospitals and five general hospitals throughout France. All patients aged ≥15 years presenting with medical complaints were included in the study. Trauma patients, those with gynaecological conditions and those with alcohol intoxication or intentional drug poisoning were excluded from the study. Each patient was assessed by two local emergency physicians to determine whether the visit was the result of an ADE. All medical records were subsequently validated by an independent group of medical lecturers in iatrogenic disorders.
Results: Out of a total of 1937 patients consulting, 1562 were taking at least one drug during the previous week and were included for analysis; 328 (21%; 95% CI 19, 23) of these patients consulted an emergency physician because of an ADE. Patients with ADEs were older than those without (mean age 63.5 vs 54.8 years; p < 0.0001). Furthermore, ADE patients were more likely to have a higher severity presentation than the non-ADE group (p = 0.019). The number of drug exposures was significantly higher in patients with an ADE than in those without (mean number of medications 5.17 vs 3.82; p < 0.0001). On multivariate analysis, only age and the number of medications taken were significantly associated with adverse events. In total, 410 drugs were incriminated in the occurrence of 328 ADEs. The most frequently incriminated drug classes were: (i) psychotropic agents (n = 84; 20.5%); (ii) diuretics (n = 48; 11.7%), anticoagulants (n = 38; 9.3%) and other cardiovascular drugs (n = 63; 15.4%); and (iii) analgesics, including NSAIDs (n = 57; 13.9%). Preventability could be assessed in 280 of the 328 cases. In 106 cases (37.9%), the ADE was judged to be preventable.
Conclusion: ADEs leading to emergency department visits are frequent, and many are preventable, confirming that there is a need to develop prevention strategies.
Literature
1.
go back to reference Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef
2.
go back to reference Pouyanne P, Haramburu F, Imbs JL, et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 2000; 320: 1036PubMedCrossRef Pouyanne P, Haramburu F, Imbs JL, et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 2000; 320: 1036PubMedCrossRef
3.
go back to reference Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87–94PubMedCrossRef Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87–94PubMedCrossRef
4.
go back to reference Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289(9): 1107–16PubMedCrossRef Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289(9): 1107–16PubMedCrossRef
5.
go back to reference Olivier P, Boulbés O, Tubery M, et al. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Drug Saf 2002; 25(14): 1035–44PubMedCrossRef Olivier P, Boulbés O, Tubery M, et al. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Drug Saf 2002; 25(14): 1035–44PubMedCrossRef
6.
go back to reference Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports. Am J Health Syst Pharm 2002; 59: 1742–9PubMed Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports. Am J Health Syst Pharm 2002; 59: 1742–9PubMed
7.
go back to reference Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring: cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6Suppl. 3: S79–90PubMedCrossRef Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring: cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6Suppl. 3: S79–90PubMedCrossRef
8.
go back to reference Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277(4): 307–11PubMedCrossRef Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277(4): 307–11PubMedCrossRef
9.
go back to reference Doucet J, Jego A, Noel D, et al. Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly: a prospective study. Clin Drug Invest 2002; 22: 385–92CrossRef Doucet J, Jego A, Noel D, et al. Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly: a prospective study. Clin Drug Invest 2002; 22: 385–92CrossRef
10.
go back to reference Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348(16): 1556–64PubMedCrossRef Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348(16): 1556–64PubMedCrossRef
11.
go back to reference Queneau P, Bergmann JF. Prévention de la iatrogénie évitable: quand la sécurité des malades se conjugue avec les économies de santé. Therapie 2001; 56: 163–8PubMed Queneau P, Bergmann JF. Prévention de la iatrogénie évitable: quand la sécurité des malades se conjugue avec les économies de santé. Therapie 2001; 56: 163–8PubMed
12.
go back to reference Begaud B, Evreux JC, Jouglard J, et al. Unexpected or toxic drug reaction assessment (imputation): actualization of the method used in France. Therapie 1985; 40: 115–8 Begaud B, Evreux JC, Jouglard J, et al. Unexpected or toxic drug reaction assessment (imputation): actualization of the method used in France. Therapie 1985; 40: 115–8
13.
go back to reference Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000; 22(6): 415–23PubMedCrossRef Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000; 22(6): 415–23PubMedCrossRef
14.
go back to reference Fourestie V, Roussignol E, Elkarrat D, et al. Classification clinique des malades aux urgences: définition et reproductibilité. Rean Urg 1994; 3: 573–8CrossRef Fourestie V, Roussignol E, Elkarrat D, et al. Classification clinique des malades aux urgences: définition et reproductibilité. Rean Urg 1994; 3: 573–8CrossRef
15.
go back to reference Hafner JW, Belknap SM, Squillante MD, et al. Adverse drug events in emergency department patients. Ann Emerg Med 2002; 39(3): 258–67PubMedCrossRef Hafner JW, Belknap SM, Squillante MD, et al. Adverse drug events in emergency department patients. Ann Emerg Med 2002; 39(3): 258–67PubMedCrossRef
16.
go back to reference Vital-Durand D. Epidémiologie des effets indésirables des médicaments. In: Guillevin L, editor. Pathologie iatrogène. Paris: Masson, 1993: 1–7 Vital-Durand D. Epidémiologie des effets indésirables des médicaments. In: Guillevin L, editor. Pathologie iatrogène. Paris: Masson, 1993: 1–7
17.
go back to reference Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301–6PubMedCrossRef Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301–6PubMedCrossRef
18.
go back to reference Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med 2000; 160: 2717–28PubMedCrossRef Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med 2000; 160: 2717–28PubMedCrossRef
19.
go back to reference Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39(11): 1093–9PubMed Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39(11): 1093–9PubMed
20.
go back to reference Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199–205PubMedCrossRef Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199–205PubMedCrossRef
21.
go back to reference Faich GA, Knapp D, Dreis M, et al. National adverse drug reaction surveillance: 1985. JAMA 1987; 257: 2068–70PubMedCrossRef Faich GA, Knapp D, Dreis M, et al. National adverse drug reaction surveillance: 1985. JAMA 1987; 257: 2068–70PubMedCrossRef
22.
go back to reference Martin RM, Biswas PN, Freemantle SN, et al. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol 1998; 46: 505–11PubMedCrossRef Martin RM, Biswas PN, Freemantle SN, et al. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol 1998; 46: 505–11PubMedCrossRef
23.
go back to reference Ebbesen J, Buajordet I, Erikssen J, et al. Drug-related death in a department of internal medicine. Arch Intern Med 2001; 161: 2317–23PubMedCrossRef Ebbesen J, Buajordet I, Erikssen J, et al. Drug-related death in a department of internal medicine. Arch Intern Med 2001; 161: 2317–23PubMedCrossRef
24.
go back to reference Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58(12): 1126–32PubMed Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58(12): 1126–32PubMed
25.
go back to reference Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277(4): 312–7PubMedCrossRef Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277(4): 312–7PubMedCrossRef
26.
go back to reference Curtis LH, Ostbye T, Sendersky V, et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 2004; 164(23): 1621–5PubMedCrossRef Curtis LH, Ostbye T, Sendersky V, et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 2004; 164(23): 1621–5PubMedCrossRef
27.
go back to reference Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282(3): 267–70PubMedCrossRef Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282(3): 267–70PubMedCrossRef
28.
go back to reference Kizer KW. Establishing health care performance standards in an era of consumerism. JAMA 2001; 286(10): 1213–7PubMedCrossRef Kizer KW. Establishing health care performance standards in an era of consumerism. JAMA 2001; 286(10): 1213–7PubMedCrossRef
29.
go back to reference Queneau P, Chabot JM, Rajaona H, et al. Iatrogenic disease observed in a hospital setting. II. Analysis of causes and suggestions for novel preventive measures [in French]. Bull Acad Natl Med 1992; 176(5): 651–64PubMed Queneau P, Chabot JM, Rajaona H, et al. Iatrogenic disease observed in a hospital setting. II. Analysis of causes and suggestions for novel preventive measures [in French]. Bull Acad Natl Med 1992; 176(5): 651–64PubMed
Metadata
Title
Emergency Department Visits Caused by Adverse Drug Events
Results of a French Survey
Authors
Patrice Queneau
Bernard Bannwarth
Françoise Carpentier
Jean-Michel Guliana
Jacques Bouget
Béatrice Trombert
Xavier Leverve
Frédéric Lapostolle
Stephen W Borron
Professor Frédéric Adnet
Publication date
01-01-2007
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 1/2007
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200730010-00008

Other articles of this Issue 1/2007

Drug Safety 1/2007 Go to the issue

Original Research Article

Clozapine-Associated Myocarditis